Literature DB >> 28663103

Quantitative Imaging Approaches to Study the CAR Immunological Synapse.

Malini Mukherjee1, Emily M Mace2, Alexandre F Carisey2, Nabil Ahmed3, Jordan S Orange4.   

Abstract

The lytic immunological synapse (IS) is a discrete structural entity formed after the ligation of specific activating receptors that leads to the destruction of a cancerous cell. The formation of an effector cell IS in cytotoxic T lymphocytes or natural killer cells is a hierarchical and stepwise rearrangement of structural and signaling components and targeted release of the contents of lytic granules. While recent advances in the generation and testing of cytotoxic lymphocytes expressing chimeric antigen receptors (CARs) has demonstrated their efficacy in the targeted lysis of tumor targets, the contribution and dynamics of IS components have not yet been extensively investigated in the context of engineered CAR cells. Understanding the biology of the CAR IS will be a powerful approach to efficiently guide the engineering of new CARs and help identify mechanistic problems in existing CARs. Here, we review the formation of the lytic IS and describe quantitative imaging-based measurements using multiple microscopy techniques at a single cell level that can be used in conjunction with established population-based assays to provide insight into the important cytotoxic function of CAR cells. The inclusion of this approach in the pipeline of CAR product design could be a novel and valuable innovation for the field. Published by Elsevier Inc.

Entities:  

Keywords:  CAR; chimeric antigen receptor; confocal microscopy; immune synapse; live imaging microscopy; quantitative image analysis

Mesh:

Substances:

Year:  2017        PMID: 28663103      PMCID: PMC5542801          DOI: 10.1016/j.ymthe.2017.06.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  96 in total

1.  T cell killing does not require the formation of a stable mature immunological synapse.

Authors:  Marco A Purbhoo; Darrell J Irvine; Johannes B Huppa; Mark M Davis
Journal:  Nat Immunol       Date:  2004-03-28       Impact factor: 25.606

Review 2.  CAR-T Cell Therapy for Lymphoma.

Authors:  Carlos A Ramos; Helen E Heslop; Malcolm K Brenner
Journal:  Annu Rev Med       Date:  2015-08-26       Impact factor: 13.739

3.  Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells.

Authors:  Paul J Choi; Timothy J Mitchison
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

4.  Genetic engineering of T cells in leukemia and lymphoma.

Authors:  James N Kochenderfer
Journal:  Clin Adv Hematol Oncol       Date:  2014-03

5.  Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.

Authors:  Hollie J Pegram; James C Lee; Erik G Hayman; Gavin H Imperato; Thomas F Tedder; Michel Sadelain; Renier J Brentjens
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

6.  Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

Authors:  James N Kochenderfer; Wyndham H Wilson; John E Janik; Mark E Dudley; Maryalice Stetler-Stevenson; Steven A Feldman; Irina Maric; Mark Raffeld; Debbie-Ann N Nathan; Brock J Lanier; Richard A Morgan; Steven A Rosenberg
Journal:  Blood       Date:  2010-07-28       Impact factor: 22.113

Review 7.  The cellular context of T cell signaling.

Authors:  Michael L Dustin
Journal:  Immunity       Date:  2009-04-17       Impact factor: 31.745

8.  OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.

Authors:  Andreas A Hombach; Johannes Heiders; Marcel Foppe; Markus Chmielewski; Hinrich Abken
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110

9.  Myosin IIA is required for cytolytic granule exocytosis in human NK cells.

Authors:  Milena M Andzelm; Xi Chen; Konrad Krzewski; Jordan S Orange; Jack L Strominger
Journal:  J Exp Med       Date:  2007-09-17       Impact factor: 14.307

10.  Microchip Screening Platform for Single Cell Assessment of NK Cell Cytotoxicity.

Authors:  Karolin Guldevall; Ludwig Brandt; Elin Forslund; Karl Olofsson; Thomas W Frisk; Per E Olofsson; Karin Gustafsson; Otto Manneberg; Bruno Vanherberghen; Hjalmar Brismar; Klas Kärre; Michael Uhlin; Björn Önfelt
Journal:  Front Immunol       Date:  2016-04-05       Impact factor: 7.561

View more
  23 in total

1.  Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.

Authors:  Chuan Tong; Yajing Zhang; Yang Liu; Xingyu Ji; Wenying Zhang; Yelei Guo; Xiao Han; Dongdong Ti; Hanren Dai; Chunmeng Wang; Qingming Yang; Wanli Liu; Yao Wang; Zhiqiang Wu; Weidong Han
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

Review 2.  Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.

Authors:  Ling Wu; Qianru Wei; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Cell Mol Immunol       Date:  2020-05-25       Impact factor: 11.530

3.  Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function.

Authors:  Alexander Vargas-Hernández; Agnieszka Witalisz-Siepracka; Michaela Prchal-Murphy; Klara Klein; Sanjana Mahapatra; Waleed Al-Herz; Emily M Mace; Alexandre F Carisey; Jordan S Orange; Veronika Sexl; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2019-10-07       Impact factor: 10.793

4.  Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Authors:  Belén Blanco; Ángel Ramírez-Fernández; Clara Bueno; Lidia Argemí-Muntadas; Patricia Fuentes; Óscar Aguilar-Sopeña; Francisco Gutierrez-Agüera; Samanta Romina Zanetti; Antonio Tapia-Galisteo; Laura Díez-Alonso; Alejandro Segura-Tudela; Maria Castellà; Berta Marzal; Sergi Betriu; Seandean L Harwood; Marta Compte; Simon Lykkemark; Ainhoa Erce-Llamazares; Laura Rubio-Pérez; Anaïs Jiménez-Reinoso; Carmen Domínguez-Alonso; Maria Neves; Pablo Morales; Estela Paz-Artal; Sonia Guedan; Laura Sanz; María L Toribio; Pedro Roda-Navarro; Manel Juan; Pablo Menéndez; Luis Álvarez-Vallina
Journal:  Cancer Immunol Res       Date:  2022-04-01       Impact factor: 11.151

5.  Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

Authors:  Yasushi Akahori; Linan Wang; Motohiro Yoneyama; Naohiro Seo; Satoshi Okumura; Yoshihiro Miyahara; Yasunori Amaishi; Sachiko Okamoto; Junichi Mineno; Hiroaki Ikeda; Takehiro Maki; Hiroshi Fujiwara; Yoshiki Akatsuka; Takuma Kato; Hiroshi Shiku
Journal:  Blood       Date:  2018-07-25       Impact factor: 22.113

6.  Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.

Authors:  Hannah Wurzer; Liza Filali; Céline Hoffmann; Max Krecke; Andrea Michela Biolato; Jérôme Mastio; Sigrid De Wilde; Jean Hugues François; Anne Largeot; Guy Berchem; Jérôme Paggetti; Etienne Moussay; Clément Thomas
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

7.  Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.

Authors:  May Daher; Rafet Basar; Elif Gokdemir; Natalia Baran; Nadima Uprety; Ana Karen Nunez Cortes; Mayela Mendt; Lucila Nassif Kerbauy; Pinaki P Banerjee; Mayra Shanley; Nobuhiko Imahashi; Li Li; Francesca Lorraine Wei Inng Lim; Mohsen Fathi; Ali Rezvan; Vakul Mohanty; Yifei Shen; Hila Shaim; Junjun Lu; Gonca Ozcan; Emily Ensley; Mecit Kaplan; Vandana Nandivada; Mustafa Bdiwi; Sunil Acharya; Yuanxin Xi; Xinhai Wan; Duncan Mak; Enli Liu; Xin Ru Jiang; Sonny Ang; Luis Muniz-Feliciano; Ye Li; Jing Wang; Shahram Kordasti; Nedyalko Petrov; Navin Varadarajan; David Marin; Lorenzo Brunetti; Richard J Skinner; Shangrong Lyu; Leiser Silva; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Heng Li; Natalie W Fowlkes; Ken Chen; Marina Konopleva; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2021-02-04       Impact factor: 25.476

8.  Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

Authors:  A J Davenport; R S Cross; K A Watson; Y Liao; W Shi; H M Prince; P A Beavis; J A Trapani; M H Kershaw; D S Ritchie; P K Darcy; P J Neeson; M R Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

Review 9.  Natural killer cells in pancreatic cancer stroma.

Authors:  Rachel Elizabeth Ann Fincham; Francesca Romana Delvecchio; Michelle R Goulart; Joe Poe Sheng Yeong; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

10.  Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse.

Authors:  Praneeth Chitirala; Hsin-Fang Chang; Paloma Martzloff; Christiane Harenberg; Keerthana Ravichandran; Midhat H Abdulreda; Per-Olof Berggren; Elmar Krause; Claudia Schirra; Trese Leinders-Zufall; Fritz Benseler; Nils Brose; Jens Rettig
Journal:  Elife       Date:  2020-07-22       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.